Literature DB >> 30278167

Standardized Haller and Asymmetry Index Combined for a More Accurate Assessment of Pectus Excavatum.

Sergio B Sesia1, Margarete Heitzelmann2, Sabine Schaedelin3, Olaf Magerkurth4, Gregor J Kocher5, Ralph A Schmid5, Frank-Martin Haecker6.   

Abstract

BACKGROUND: The measurement of the Haller index (HI) is not standardized, and HI does not consider the asymmetry of pectus excavatum. The aim of this study was to determine the most appropriate level for measuring the HI and to introduce the asymmetry index (AI) in order to respect the aspect of asymmetry.
METHODS: Preoperative computer tomography scans of 43 patients with pectus excavatum were retrospectively analyzed by measuring both the HI and the AI at 3 different levels: (I) sternomanubrial junction; (II) caudal end of corpus sterni; and (III) tip of the xiphoid. The control group comprised 33 patients without chest wall deformity and a HI < 3.25. For each patient HI and AI were calculated according to a standardized protocol. A McNemar test was used for statistical analyses.
RESULTS: The sensitivity of the HI was highest when measured at level II (p < 0.388), and the AI exhibited the highest sensitivity at level I. When combining both indices, the sensitivity of assessing pectus excavatum significantly increased compared with the use of HI at level II alone (p < 0.002).
CONCLUSIONS: The measurement of the HI at level II represents the most valid standardized parameter for assessment of the severity of pectus excavatum. Asymmetry, on the other hand, is best assessed by the AI measured at level I. The combination of the standardized HI and AI not only provides a much more accurate description of pectus excavatum, but also improves the comparability of pectus excavatum patients in general.
Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30278167     DOI: 10.1016/j.athoracsur.2018.07.086

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Stiffness reduction of the rib cage to perform a minimally invasive pectus excavatum repair: biomechanical evaluation.

Authors:  Ángel Gabriel Vega-Artiles; David Pérez; Oscar Martel; Alberto Cuadrado; Alejandro Yánez
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-08-02

2.  Serum lactate dehydrogenase activity and its isoenzyme patterns in patients with pectus excavatum.

Authors:  Seong Cheol Jeong; Jae Jun Kim; Yong Hwan Kim; In Sub Kim; Jung Wook Han
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

3.  Vacuum Bell: Is It a Useful Innovative Device for Pectus Excavatum Correction?

Authors:  Ioannis Loufopoulos; Ioannis G Karagiannidis; Savvas Lampridis; Sofoklis Mitsos; Nikolaos Panagiotopoulos
Journal:  Turk Thorac J       Date:  2021-05

4.  The effectiveness of double-bar correction for pectus excavatum: A comparison between the parallel bar and cross-bar techniques.

Authors:  Duk Hwan Moon; Chul Hwan Park; Mi Hyung Moon; Hyung Joo Park; Sungsoo Lee
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

5.  Factors influencing negative surgical outcomes in adult pectus excavatum patients undergoing Nuss procedure.

Authors:  Zhen Gao; Shujie Huang; Yong Tang; Sichao Wang; Weitao Zhuang; Yu Ding; Hansheng Wu; Jiming Tang; Dongkun Zhang; Haiyu Zhou; Xiaosong Ben; Liang Xie; Gang Chen; Guibin Qiao
Journal:  Ann Transl Med       Date:  2021-08

6.  Modified Nuss procedure with a novel steel bar in patients with pectus excavatum post-congenital heart surgery.

Authors:  Siming Liu; Lei Wang; Hongkun Zhang; Wenhui Zeng; Fengqing Hu; Haibo Xiao; Guoqing Li; Ju Mei; Jiaquan Zhu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-02-21

7.  Computed tomographic evaluation of pectus excavatum in 14 cats.

Authors:  Renata Komsta; Anna Łojszczyk; Piotr Dębiak; Piotr Twardowski; Barbara Lisiak
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.